Bio Essence Statistics

Total Valuation

Bio Essence has a market cap or net worth of 8.06 million. The enterprise value is 10.76 million.

Market Cap	8.06M
Enterprise Value	10.76M

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Bio Essence has 38.01 million shares outstanding. The number of shares has increased by 2.16% in one year.

Current Share Class	38.01M
Shares Outstanding	38.01M
Shares Change (YoY)	+2.16%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	90.49%
Owned by Institutions (%)	n/a
Float	3.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.28
PB Ratio	-2.54
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	10.47
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.53
EV / Sales	31.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.11

Current Ratio	0.11
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-238.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-24.46%
Return on Invested Capital (ROIC)	-43.51%
Return on Capital Employed (ROCE)	17.85%
Revenue Per Employee	173,065
Profits Per Employee	-824,244
Employee Count	2
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.46% in the last 52 weeks. The beta is 14.85, so Bio Essence's price volatility has been higher than the market average.

Beta (5Y)	14.85
52-Week Price Change	-18.46%
50-Day Moving Average	0.22
200-Day Moving Average	0.57
Relative Strength Index (RSI)	46.21
Average Volume (20 Days)	113

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Essence had revenue of 346,129 and -1.65 million in losses. Loss per share was -0.04.

Revenue	346,129
Gross Profit	237,665
Operating Income	-512,702
Pretax Income	-1.65M
Net Income	-1.65M
EBITDA	-511,994
EBIT	-512,702
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	2.74M
Net Cash	-2.74M
Net Cash Per Share	-0.07
Equity (Book Value)	-3.17M
Book Value Per Share	-0.08
Working Capital	-2.87M

Full Balance Sheet

Cash Flow

Operating Cash Flow	769,409
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	68.66%
Operating Margin	-148.12%
Pretax Margin	-476.03%
Profit Margin	n/a
EBITDA Margin	-147.92%
EBIT Margin	-148.12%
FCF Margin	n/a

Dividends & Yields

Bio Essence does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.16%
Shareholder Yield	n/a
Earnings Yield	-20.46%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a